Prescott Group Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
+444
New +$249K 0.02% 290
2015
Q4
Sell
-21,758
Closed -$1.62M 165
2015
Q3
$1.62M Hold
21,758
0.39% 76
2015
Q2
$1.4M Buy
21,758
+3,758
+21% +$260K 0.28% 102
2015
Q1
$1.39M Hold
18,000
0.28% 101
2014
Q4
$1.33M Buy
+18,000
New +$1.26M 0.22% 124

Other funds holding IDXX

Prescott Group Capital Management's IDXX Position: Q2 2026 in Review

Prescott Group Capital Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 444 shares worth $234K. The stake represents 0.02% of the portfolio and ranks #290 among its holdings. This is a return to the name: Prescott Group Capital Management previously reported a position in IDXX as recently as Q3 2015.

Prescott Group Capital Management first reported a position in IDXX in Q4 2014 and has held it in 5 quarters since. The position peaked at $1.62M in Q3 2015. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Prescott Group Capital Management held 444 shares of Idexx Laboratories worth $234K as of Q2 2026.
  • Idexx Laboratories was a new Prescott Group Capital Management position in Q2 2026.
  • Idexx Laboratories made up 0.02% of Prescott Group Capital Management's portfolio in Q2 2026, its #290 holding.
  • Prescott Group Capital Management first reported a position in Idexx Laboratories in Q4 2014 and has held it in 5 quarters since.
  • Prescott Group Capital Management's Idexx Laboratories position peaked at $1.62M in Q3 2015.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Prescott Group Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.